| NCT ID | Title | Status | Phases | Start Date | Completion Date | Primary Completion Date |
|---|---|---|---|---|---|---|
| NCT04832438 | 9-ING-41 Plus Carboplatin in Patients With Advanced, Metastatic Salivary Gland Carcinoma | WITHDRAWN | PHASE2 | 2030-12-18 | 2034-06-18 | 2033-06-18 |
| NCT04218071 | Actuate 1901: 9-ING-41 in Myelofibrosis | COMPLETED | PHASE2 | 2020-08-20 | 2024-01-18 | 2022-10-13 |
| NCT04239092 | 9-ING-41 in Pediatric Patients With Refractory Malignancies. | TERMINATED | PHASE1 | 2020-06-05 | 2025-07-07 | 2025-07-07 |
| NCT03678883 | 9-ING-41 in Patients with Advanced Cancers | ACTIVE_NOT_RECRUITING | PHASE2 | 2019-01-04 | 2026-01 | 2025-01 |